Andrea S. James is CFO at Oncocyte Corp (OCX). They have made 3 open-market trades across 1 company since 2024, most recently 2026-03-26.
CIK 0002027010
3 open-market purchases totalling $646K since 2024, never a sale. Too few scored purchases to measure a record yet.
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.